In 2022, the global market for botulinum toxin A, also known as Botox A. was valued at almost $6.6 billion and is projected to increase at a compound annual growth rate (CAGR) of 6.5% over the forecast period, reaching almost $10.2 billion.
This report provides a full suite of information on the global market for botulinum toxin A, including both aesthetic and therapeutic segments. We also offer detailed data on the total botulinum toxin A procedure volume on a regional and country level, so that you can gain a comprehensive understanding of the global landscape and identify key growth opportunities.
In 2022, Allergan Aesthetics, which is now part of AbbVie, held the leading position in the global botulinum toxin A market. Their BOTOX® solution, an injectable containing onabotulinum toxin A, is specifically formulated for the treatment of glabellar frown lines, periorbital lines (crow's feet), and forehead lines in adults. Additionally, in February 2021, AbbVie received FDA approval for the treatment of detrusor overactivity linked with certain neurological conditions in pediatric patients.
This report provides a full suite of information on the global market for botulinum toxin A, including both aesthetic and therapeutic segments. We also offer detailed data on the total botulinum toxin A procedure volume on a regional and country level, so that you can gain a comprehensive understanding of the global landscape and identify key growth opportunities.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL BOTULINUM TOXIN A MARKET INSIGHTS
The global botulinum toxin A market is experiencing significant growth, largely due to the increasing popularity and acceptance of minimally invasive cosmetic procedures, particularly injectables. As patients seek out affordable treatments with minimal downtime, injectables have become increasingly popular. Additionally, preventative treatments have gained momentum, as they have proven to be an easier and less expensive method for treating wrinkles before they become more pronounced. On the other hand, deeply etched lines may require more intensive treatments.GLOBAL BOTULINUM TOXIN A MARKET SHARE INSIGHTS
The global botulinum toxin A market was dominated by Allergan Aesthetics, Galderma, Merz Aesthetics and Johnson & Johnson. Collectively, these companies accounted for over half of the overall market value.In 2022, Allergan Aesthetics, which is now part of AbbVie, held the leading position in the global botulinum toxin A market. Their BOTOX® solution, an injectable containing onabotulinum toxin A, is specifically formulated for the treatment of glabellar frown lines, periorbital lines (crow's feet), and forehead lines in adults. Additionally, in February 2021, AbbVie received FDA approval for the treatment of detrusor overactivity linked with certain neurological conditions in pediatric patients.
MARKET SEGMENTATION SUMMARY
- Aesthetic Botulinum Toxin A Market
- Therapeutic Botulinum Toxin A Market
RESEARCH SCOPE SUMMARY
- Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
- Base Year: 2022
- Forecast Period: 2023-2029
- Historical Data: 2019-2022
- Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
- Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
- Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Table of Contents
- Executive Summary
- Global Botulinum Toxin A Market Overview
- Competitive Analysis
- Markets Included
- Regions Included
- Introduction
- Procedure Numbers
- Market Overview
- By Segment
- By Region
- Market Analysis and Forecast
- Total Botulinum Toxin A Market
- Aesthetic Botulinum Toxin A Market
- Therapeutic Botulinum Toxin A Market
- Drivers and Limiters
- Market Drivers
- Market Limiters
- Competitive Market Share Analysis
List of Charts
Chart 6-1: Botulinum Toxin A Market, Global, 2022 & 2029
Chart 6-2: Botulinum Toxin A Procedures, Global, 2022
Chart 6-3: Botulinum Toxin A Procedures by Region, Global, 2019-2029
Chart 6-4: Botulinum Toxin A Market by Segment, Global, 2019-2029
Chart 6-5: Botulinum Toxin A Market by Region, Global, 2019-2029
Chart 6-6: Leading Competitors, Botulinum Toxin A Market, Global, 2022
List of Figures
Figure 6-1: Botulinum Toxin A Markets Covered
Figure 6-2: Botulinum Toxin A Regions Covered, Global (1 of 2)
Figure 6-3: Botulinum Toxin A Regions Covered, Global (2 of 2)
Figure 6-4: Botulinum Toxin A Procedures by Region, Global, 2019-2029
Figure 6-5: Botulinum Toxin A Procedures by Country, North America, 2019-2029
Figure 6-6: Botulinum Toxin A Procedures by Country, Latin America, 2019-2029 (1 of 2)
Figure 6-7: Botulinum Toxin A Procedures by Country, Latin America, 2019-2029 (2 of 2)
Figure 6-8: Botulinum Toxin A Procedures by Country, Western Europe, 2019-2029
Figure 6-9: Botulinum Toxin A Procedures by Country, Central & Eastern Europe, 2019-2029 (1 of 2)
Figure 6-10: Botulinum Toxin A Procedures by Country, Central & Eastern Europe, 2019-2029 (2 of 2)
Figure 6-11: Botulinum Toxin A Procedures by Country, Middle East, 2019-2029
Figure 6-12: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019-2029 (1 of 3)
Figure 6-13: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019-2029 (2 of 3)
Figure 6-14: Botulinum Toxin A Procedures by Country, Asia-Pacific, 2019-2029 (3 of 3)
Figure 6-15: Botulinum Toxin A Procedures by Country, Africa, 2019-2029
Figure 6-16: Botulinum Toxin A by Segment, Global, 2019-2029 (US$M)
Figure 6-17: Botulinum Toxin A Market by Region, Global, 2019-2029 (US$M)
Figure 6-18: Botulinum Toxin A Market, Global, 2019-2029
Figure 6-19: Units Sold (100IU) by Region Botulinum Toxin A Market, Global, 2019-2029
Figure 6-20: Average Selling Price by Region, Botulinum Toxin A Market, Global, 2019-2029 (US$)
Figure 6-21: Market Value by Region, Botulinum Toxin A Market, Global, 2019-2029 (US$M)
Figure 6-22: Aesthetic Botulinum Toxin A Market, Global, 2019-2029
Figure 6-23: Units Sold (100IU) by Region, Aesthetic Botulinum Toxin A Market, Global, 2019-2029
Figure 6-24: Average Selling Price by Region, Aesthetic Botulinum Toxin A Market, Global, 2019-2029 (US$)
Figure 6-25: Market Value by Region, Aesthetic Botulinum Toxin A Market, Global, 2019-2029 (US$M)
Figure 6-26: Therapeutic Botulinum Toxin A Market, Global, 2019-2029
Figure 6-27: Units Sold (100IU) by Region, Therapeutic Botulinum Toxin A Market, Global, 2019-2029
Figure 6-28: Average Selling Price by Region, Therapeutic Botulinum Toxin A Market, Global, 2019-2029 (US$)
Figure 6-29: Market Value by Region, Therapeutic Botulinum Toxin A Market, Global, 2019-2029 (US$M)
Figure 6-30: Leading Competitors, Botulinum Toxin A Market, Global, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie
- Galderma
- Merz Aesthetics
- Evolus
- Hugel
- Lanzhou Institute of Biological Products
- Medytox
- Revance
